Ani Pharmaceuticals Inc (ANIP)

10:10 AM

ANI Pharmaceuticals initiates Phase IV trial of gel for acute gout flares - Yahoo

10:10 AM

07:31 AM

ANI Pharmaceuticals Approves Key Proposals at Annual Meeting - TipRanks

07:31 AM

07:13 AM

ANI Pharmaceuticals Expands Stock Plans and Shares - Investing.com

07:13 AM

May 22, 2025

Have Insiders Sold ANI Pharmaceuticals Shares Recently? - simplywall.st

May 22, 2025

May 22, 2025

ANI Pharmaceuticals Launches Phase 4 Trial of Cortrophin Gel for Acute Gout Flares - marketscreener.com

May 22, 2025

May 22, 2025

ANI Pharmaceuticals (ANIP) Starts Phase 4 Trial for Acute Gout Treatment | ANIP Stock News - GuruFocus

May 22, 2025

May 22, 2025

ANI Pharmaceuticals Announces Initiation of Phase 4 - GlobeNewswire

May 22, 2025

May 21, 2025

ANI Raises Generics Guidance As Exclusive Prucalopride Drives Growth - insights.citeline.com

May 21, 2025

May 20, 2025

ANI Pharmaceuticals To Present At H.C. Wainwright BioConnect Conference; Webcast At 1:30 PM ET - Nasdaq

May 20, 2025

May 16, 2025

We Think Shareholders Will Probably Be Generous With ANI Pharmaceuticals, Inc.'s (NASDAQ:ANIP) CEO Compensation - simplywall.st

May 16, 2025

May 13, 2025

Analysts Offer Insights on Healthcare Companies: ANI Pharmaceuticals (ANIP), Voyager Therapeutics (VYGR) and Privia Health Group (PRVA) - The Globe and Mail

May 13, 2025

May 12, 2025

ANI Pharmaceuticals (ANIP) Price Target Raised by Raymond James - GuruFocus

May 12, 2025

May 12, 2025

ANI Pharmaceuticals to Participate at the H.C. Wainwright 3rd Annual BioConnect Conference at NASDAQ - GlobeNewswire

May 12, 2025

May 12, 2025

ANI Pharmaceuticals (ANIP) Receives Buy Rating from Guggenheim | - GuruFocus

May 12, 2025

May 12, 2025

ANI Pharmaceuticals (ANIP) Receives Buy Rating from Guggenheim | ANIP Stock News - GuruFocus

May 12, 2025

May 10, 2025

ANI Pharmaceuticals raises 2025 revenue guidance to $768M-$793M with 25%-29% growth - MSN

May 10, 2025

May 10, 2025

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q1 2025 Earnings Call Transcript - Insider Monkey

May 10, 2025

May 10, 2025

Earnings call transcript: ANI Pharmaceuticals beats Q1 2025 forecasts, stock surges - Investing.com UK

May 10, 2025

May 10, 2025

ANI Pharmaceuticals Inc (ANIP) Q1 2025 Earnings Call Highlights: Record Revenue and Strategic ... By GuruFocus - Investing.com Canada

May 10, 2025

May 10, 2025

Decoding ANI Pharmaceuticals Inc (ANIP): A Strategic SWOT Insigh - GuruFocus

May 10, 2025

May 10, 2025

Decoding ANI Pharmaceuticals Inc (ANIP): A Strategic SWOT Insight - GuruFocus

May 10, 2025

May 10, 2025

ANI Pharmaceuticals Reports Record Q1 2025 Results - TipRanks

May 10, 2025

May 09, 2025

Earnings call transcript: ANI Pharmaceuticals beats Q1 2025 forecasts, stock surges By Investing.com - Investing.com South Africa

May 09, 2025

May 09, 2025

Cortrophin Demand Is Soaring For ANI Pharma, CEO Says Well-Positioned To Mitigate Potential Tariff Impact - AOL.com

May 09, 2025

May 09, 2025

ANI: Q1 Earnings Snapshot - The Washington Post

May 09, 2025

May 09, 2025

Transcript : ANI Pharmaceuticals, Inc., Q1 2025 Earnings Call, May 09, 2025 - marketscreener.com

May 09, 2025

May 09, 2025

Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year? - Yahoo Finance

May 09, 2025

May 09, 2025

ANI Pharmaceuticals Boosts Q1 Revenue with Strong Performance | - GuruFocus

May 09, 2025

May 09, 2025

ANI Pharmaceuticals (ANIP) Tops Q1 Earnings and Revenue Estimates - Yahoo Finance

May 09, 2025

May 09, 2025

ANI Pharmaceuticals, Inc. Q1 Profit Decreases, But Beats Estimates - Nasdaq

May 09, 2025

May 09, 2025

ANI Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Raises 2025 Guidance - The Manila Times

May 09, 2025

May 09, 2025

ANI Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 09, 2025

May 09, 2025

ANI Pharmaceuticals (NASDAQ:ANIP) Reports Strong Q1, Full-Year Outlook Slightly Exceeds Expectations - FinancialContent

May 09, 2025

May 09, 2025

(ANIP) ANI Pharmaceuticals Expects Fiscal Year 2025 Revenue Range $768M$793M - marketscreener.com

May 09, 2025

May 09, 2025

(ANIP) ANI Pharmaceuticals Forecasts Fiscal Year 2025 Adjusted EPS Range $6.27$6.62 - marketscreener.com

May 09, 2025

May 08, 2025

ANI Pharmaceuticals to Report Q1 Earnings: Is a Beat in the Cards? - MSN

May 08, 2025

May 08, 2025

ANI Pharmaceuticals Files Proxy for 2025 Meeting - TipRanks

May 08, 2025

May 08, 2025

ANI Pharmaceuticals Set to Announce Earnings Results: Key ExpectationsNews and Statistics - IndexBox

May 08, 2025

May 08, 2025

Earnings To Watch: ANI Pharmaceuticals (ANIP) Reports Q1 Results Tomorrow - Yahoo Finance

May 08, 2025

May 06, 2025

ANI Pharmaceuticals: A Short-Term Buying Opportunity (NASDAQ:ANIP) - Seeking Alpha

May 06, 2025

May 05, 2025

ANI Pharmaceuticals Reports Record Fourth Quarter and Full-Year 2024 Financial Results and Raises 2025 Guidance - ADVFN

May 05, 2025

May 05, 2025

ANI Pharmaceuticals (ANIP) Highlights Promising Cortrophin Gel P - GuruFocus

May 05, 2025

May 05, 2025

ANI Pharmaceuticals, Inc. (ANIP) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance

May 05, 2025

May 05, 2025

ANI Pharmaceuticals Announces Presentation of Preclinical Data on the Use of Purified Cortrophin® Gel in an Experimental Autoimmune Uveitis (EAU) Mouse Model - GlobeNewswire

May 05, 2025

May 05, 2025

Breakthrough: ANI's Cortrophin Gel Achieves Dose-Dependent Success in Autoimmune Eye Disease Trial - Stock Titan

May 05, 2025

May 02, 2025

ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance

May 02, 2025

May 02, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

May 02, 2025